Home
Conditions
Blood Protein Disorders

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies

Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT00891072

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blood Protein Disorders, +121 more
Locations: Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse

NCT00335348

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Completed

Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma

NCT00017381

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +78 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia

NCT00020800

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Walter Reed Army Medical Center Washington D.C., District of Columbia, United States

View all 18 locations

View Trial Details

Completed

Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function

NCT00118170

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +83 more
Locations: Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States

View Trial Details

Completed

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00027560

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma

NCT00124605

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00253578

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia

NCT00142181

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Beth Isreal Deaconness Medical Center Boston, Massachusetts, United States

Dana-farber Cancer Insitiute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma

NCT00882063

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Jaslok Hospital & Research Centre Mumbai, Maharashtra, India

Shatabdi Superspeciality Hospital Nashik, Maharashtra, India

Rajiv Gandhi Cancer Institute And Research Centre Delhi, National Capital Territory of Delhi, India

Institute Rotary Cancer Hospital,All India Institute Of Medical Sciences(AIIMS) New Delhi, India

View Trial Details

Blood Protein Disorders

Blood Protein Disorders trial results

Related conditions